| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of Pear1 does not affect murine platelet function in vivo
|
Criel, Maarten
|
|
2016
|
146 |
C |
p. 76-83
8 p.
|
artikel
|
| 2 |
A combined deficiency of tissue factor and PAR-4 is associated with fatal pulmonary hemorrhage in mice
|
Bode, Michael F.
|
|
2016
|
146 |
C |
p. 46-50
5 p.
|
artikel
|
| 3 |
Acute intraoperative heparin-induced thrombocytopenia (HIT) and thrombosis during coronary artery bypass grafting: Two case reports providing evidence for the role of preoperative LMWH in triggering sensitization
|
Khoury, M.
|
|
2016
|
146 |
C |
p. 126-130
5 p.
|
artikel
|
| 4 |
Acute intraoperative HIT during heart surgery: Why so rare?
|
Warkentin, Theodore E.
|
|
2016
|
146 |
C |
p. 110-112
3 p.
|
artikel
|
| 5 |
Chemotherapy treatment of multiple myeloma patients increases circulating levels of endothelial microvesicles
|
Hall, Jessica
|
|
2016
|
146 |
C |
p. 20-22
3 p.
|
artikel
|
| 6 |
Ciraparantag for enoxaparin reversal: Adding to the evidence
|
Weitz, Jeffrey I.
|
|
2016
|
146 |
C |
p. 106-107
2 p.
|
artikel
|
| 7 |
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin
|
Ansell, Jack E.
|
|
2016
|
146 |
C |
p. 113-118
6 p.
|
artikel
|
| 8 |
Clinical and laboratory predictors of deep vein thrombosis after acute stroke: Does D-dimer really improve predictive power?
|
Balogun, Ibrahim O.
|
|
2016
|
146 |
C |
p. 133-134
2 p.
|
artikel
|
| 9 |
Clinical and laboratory predictors of deep vein thrombosis after acute stroke; does D-dimer really improve predictive power?
|
Kola, Vasilis
|
|
2016
|
146 |
C |
p. 131-132
2 p.
|
artikel
|
| 10 |
Corrigendum to ‘Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer”, [Thromb. Res. 141 (2016) 39–48]
|
Claussen, Carlota
|
|
2016
|
146 |
C |
p. 135-
1 p.
|
artikel
|
| 11 |
D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment
|
Kearon, C.
|
|
2016
|
146 |
C |
p. 119-125
7 p.
|
artikel
|
| 12 |
Decreased circulating thrombomodulin is improved by tadalafil therapy in hypoxemic patients with advanced pulmonary arterial hypertension
|
Maeda, N.Y.
|
|
2016
|
146 |
C |
p. 15-19
5 p.
|
artikel
|
| 13 |
Degree of obesity influences the relationship of PAI-1 with body fat distribution and metabolic variables in African women
|
Barnard, Sunelle A.
|
|
2016
|
146 |
C |
p. 95-102
8 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2016
|
146 |
C |
p. IFC-
1 p.
|
artikel
|
| 15 |
Editorial comment: D-dimer to guide long-term anticoagulant treatment duration - Have we gotten anywhere?
|
Le Gal, Grégoire
|
|
2016
|
146 |
C |
p. 108-109
2 p.
|
artikel
|
| 16 |
Idarucizumab for dabigatran reversal – Does one dose fit all?
|
Rottenstreich, Amihai
|
|
2016
|
146 |
C |
p. 103-104
2 p.
|
artikel
|
| 17 |
Impact of genetic variation in the 5-HT transporter and receptor on platelet function in patients with stable CAD taking aspirin
|
Bajrangee, Amrit
|
|
2016
|
146 |
C |
p. 51-55
5 p.
|
artikel
|
| 18 |
Interactions between depolymerized fucosylated glycosaminoglycan and coagulation proteases or inhibitors
|
Xiao, Chuang
|
|
2016
|
146 |
C |
p. 59-68
10 p.
|
artikel
|
| 19 |
Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database
|
Trinh-Duc, Albert
|
|
2016
|
146 |
C |
p. 43-45
3 p.
|
artikel
|
| 20 |
Inverted erythrocyte membranes demonstrate β2GPI-antiphospholipid antibody interactions and membrane crosslinking
|
Bloemen, Saartje
|
|
2016
|
146 |
C |
p. 89-94
6 p.
|
artikel
|
| 21 |
Normal hemostatic parameters in children and young adults with α-thalassemia diseases
|
Sirachainan, Nongnuch
|
|
2016
|
146 |
C |
p. 35-42
8 p.
|
artikel
|
| 22 |
Plasma composition distribution in cancer: Discrimination by thrombin and factor Xa generation
|
Gissel, Matthew
|
|
2016
|
146 |
C |
p. 56-58
3 p.
|
artikel
|
| 23 |
Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model
|
Hosokawa, Kazuya
|
|
2016
|
146 |
C |
p. 69-75
7 p.
|
artikel
|
| 24 |
Pregnancy and non-pregnancy related ovarian vein thrombosis: Clinical course and outcome
|
Rottenstreich, Amihai
|
|
2016
|
146 |
C |
p. 84-88
5 p.
|
artikel
|
| 25 |
Significance of fully automated tests for the diagnosis of antiphospholipid syndrome
|
Oku, Kenji
|
|
2016
|
146 |
C |
p. 1-6
6 p.
|
artikel
|
| 26 |
Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules
|
Plug, Tom
|
|
2016
|
146 |
C |
p. 7-14
8 p.
|
artikel
|
| 27 |
The clinical relevance of altered fibrinogen packaging in the presence of 17β-estradiol and progesterone
|
Swanepoel, Albe C.
|
|
2016
|
146 |
C |
p. 23-34
12 p.
|
artikel
|
| 28 |
World Thrombosis Day
|
Versteeg, Henri H.
|
|
2016
|
146 |
C |
p. 105-
1 p.
|
artikel
|
Tijdschrift beschrijving